Overview

Effect of W-3 Polyunsaturated Fatty Acids on Serum Albumin Concentration in Patients With Acute Heart Failure, Hypoalbuminemia, and High Inflammatory Activity

Status:
Completed
Trial end date:
2018-06-01
Target enrollment:
0
Participant gender:
All
Summary
Assess whether high doses of ?-3 fatty acids added to standard treatment of patients with acute hearta failure, hypoalbuminemia and high inflammatory activity, promotes an increase in serum albumin
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hospital San Juan de la Cruz
Treatments:
Eicosapentaenoic acid ethyl ester
Criteria
Inclusion Criteria:

- Patients aged 18 years or olders hospitalized for acute heart failure, chronic
decompensated or new onset of any etiology, presenting hypoalbuminemia (serum albumin
?3,4 g / dl) and high inflammatory activity (CRP ?2,5 mg / dl).

Exclusion Criteria:

- Impending doom

- Participating in other clinical trials

- Treatment with ?-3 acids in the last month prior to admission

- Percutaneous or surgical treatment of the cause of heart failure during
hospitalization.

- Pregnant women.

- Renal failure on dialysis.

- Chronic liver disease Child-Pugh B or C.

- Acute infectious process.

- Active malignant neoplasia.